World’s Largest Companies Place Bets on Nanomaterials

With nanotechnology shifting from an emphasis on R&D to a focus on commercialization – with $147 billion worth of products enabled by nanotech sold in 2007 – the strategies of global corporations and start-ups working on nanotechnology have shifted, according to a new report by Lux Research.

“Executives at global corporations are no longer in the dark on nanotechnology,” said Jurron Bradley, Ph.D., Senior Analyst at Lux Research. “While some skepticism still exists, they have learned from past flops and have instituted an ‘open innovation’ model to minimize risk.”

To analyze the strategies of global corporations and nanomaterial specialists, Lux Research conducted a new survey of top executives at 31 leading global corporations active in nanotechnology, and drew on data from over 1,000 primary interviews Lux Research Analysts conduct with technology developers annually. The study concludes that:

Awareness of nanotech is still growing – some 65% of global corporations say senior management has high awareness of nanotechnology, almost double what companies said two years ago.

Virtually every large company has an explicit nanotech strategy, most often decentralized. A solid 94% of respondents report having a specific strategy for exploiting nanotech innovation, and 65% described a decentralized organizational structure to nanotech.

Corporations are looking to external innovators to complement internal nanotech efforts – 100% of the companies interviewed cited external cooperation with universities, start-ups, or corporations as key to their strategies. Companies see such collaborations as attractive alternatives to share costs and risks.

Nanomaterial environmental, health, and safety (EHS) issues are both an increasing priority for start-ups to address, and for large companies to manage.

“Nanotech EHS remains topic A for companies developing nanomaterial applications,” noted Kristin Abkemeier, Ph.D., Analyst at Lux Research. “If they can’t deal with real risks, perceptual risks, and regulations, they won’t be able to profit. However, after several years of growing debate and ongoing uncertainty, the picture is finally beginning to clear up.”

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.